Israel Orphan Drugs Market (2025-2031) | Companies, Trends, Outlook, Segmentation, Value, Analysis, Size, Growth, Share, Industry, Forecast & Revenue

Name: Israel Orphan Drugs Market (2025-2031) | Size & Companies
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy
Keywords: Orphan Drugs Market, Israel Orphan Drugs Market, Israel Orphan Drugs Market Revenues, Israel Orphan Drugs Market Share, Israel Orphan Drugs Market Size, Israel Orphan Drugs Market Outlook, Israel Orphan Drugs Market Report, Israel Orphan Drugs Market Competition, Israel Orphan Drugs Market Overview, Israel Orphan Drugs Market Trends, Israel Orphan Drugs Market Forecast

Market Forecast By Drugs (Revlimid, Rituxan, Opdivo, Keytruda, Imbruvica, Soliris, Other Orphan Drugs), By Drug Type (Biologics, Non-Biologics), By Therapy Class (Oncology, Blood, Endocrine, Central Nervous Systems, Cardiovascular, Respiratory) And Competitive Landscape

Product Code: ETC4640019	Publication Date: Nov 2023	Updated Date: Sep 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Shubham Padhi	No. of Pages: 60	No. of Figures: 30	No. of Tables: 5

Key Highlights of the Report:

Israel Orphan Drugs Market Outlook
Market Size of Israel Orphan Drugs Market, 2024
Forecast of Israel Orphan Drugs Market, 2031
Historical Data and Forecast of Israel Orphan Drugs Revenues & Volume for the Period 2021-2031
Israel Orphan Drugs Market Trend Evolution
Israel Orphan Drugs Market Drivers and Challenges
Israel Orphan Drugs Price Trends
Israel Orphan Drugs Porter`s Five Forces
Israel Orphan Drugs Industry Life Cycle
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Drugs for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Revlimid for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Rituxan for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Opdivo for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Keytruda for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Imbruvica for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Soliris for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Other Orphan Drugs for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Drug Type for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Biologics for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Non-Biologics for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Therapy Class for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Oncology for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Blood for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Endocrine for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Central Nervous Systems for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Cardiovascular for the Period 2021-2031
Historical Data and Forecast of Israel Orphan Drugs Market Revenues & Volume By Respiratory for the Period 2021-2031
Israel Orphan Drugs Import Export Trade Statistics
Market Opportunity Assessment By Drugs
Market Opportunity Assessment By Drug Type
Market Opportunity Assessment By Therapy Class
Israel Orphan Drugs Top Companies Market Share
Israel Orphan Drugs Competitive Benchmarking By Technical and Operational Parameters
Israel Orphan Drugs Company Profiles
Israel Orphan Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Israel Orphan Drugs Market Overview

3.1 Israel Country Macro Economic Indicators

3.2 Israel Orphan Drugs Market Revenues & Volume, 2021 & 2031F

3.3 Israel Orphan Drugs Market - Industry Life Cycle

3.4 Israel Orphan Drugs Market - Porter's Five Forces

3.5 Israel Orphan Drugs Market Revenues & Volume Share, By Drugs, 2021 & 2031F

3.6 Israel Orphan Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.7 Israel Orphan Drugs Market Revenues & Volume Share, By Therapy Class, 2021 & 2031F

4 Israel Orphan Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of rare diseases in Israel

4.2.2 Government initiatives and incentives to support orphan drug development

4.2.3 Technological advancements in drug development for rare diseases

4.3 Market Restraints

4.3.1 High cost of orphan drugs leading to affordability issues

4.3.2 Limited awareness and understanding of orphan drugs among healthcare professionals and patients

5 Israel Orphan Drugs Market Trends

6 Israel Orphan Drugs Market Segmentations

6.1 Israel Orphan Drugs Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 Israel Orphan Drugs Market Revenues & Volume, By Revlimid, 2021-2031F

6.1.3 Israel Orphan Drugs Market Revenues & Volume, By Rituxan, 2021-2031F

6.1.4 Israel Orphan Drugs Market Revenues & Volume, By Opdivo, 2021-2031F

6.1.5 Israel Orphan Drugs Market Revenues & Volume, By Keytruda, 2021-2031F

6.1.6 Israel Orphan Drugs Market Revenues & Volume, By Imbruvica, 2021-2031F

6.1.7 Israel Orphan Drugs Market Revenues & Volume, By Soliris, 2021-2031F

6.2 Israel Orphan Drugs Market, By Drug Type

6.2.1 Overview and Analysis

6.2.2 Israel Orphan Drugs Market Revenues & Volume, By Biologics, 2021-2031F

6.2.3 Israel Orphan Drugs Market Revenues & Volume, By Non-Biologics, 2021-2031F

6.3 Israel Orphan Drugs Market, By Therapy Class

6.3.1 Overview and Analysis

6.3.2 Israel Orphan Drugs Market Revenues & Volume, By Oncology, 2021-2031F

6.3.3 Israel Orphan Drugs Market Revenues & Volume, By Blood, 2021-2031F

6.3.4 Israel Orphan Drugs Market Revenues & Volume, By Endocrine, 2021-2031F

6.3.5 Israel Orphan Drugs Market Revenues & Volume, By Central Nervous Systems, 2021-2031F

6.3.6 Israel Orphan Drugs Market Revenues & Volume, By Cardiovascular, 2021-2031F

6.3.7 Israel Orphan Drugs Market Revenues & Volume, By Respiratory, 2021-2031F

7 Israel Orphan Drugs Market Import-Export Trade Statistics

7.1 Israel Orphan Drugs Market Export to Major Countries

7.2 Israel Orphan Drugs Market Imports from Major Countries

8 Israel Orphan Drugs Market Key Performance Indicators

8.1 Number of orphan drug designations granted by regulatory authorities in Israel

8.2 Percentage of healthcare professionals trained on orphan drug prescribing guidelines

8.3 Patient enrollment rates in clinical trials for orphan drugs

9 Israel Orphan Drugs Market - Opportunity Assessment

9.1 Israel Orphan Drugs Market Opportunity Assessment, By Drugs, 2021 & 2031F

9.2 Israel Orphan Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.3 Israel Orphan Drugs Market Opportunity Assessment, By Therapy Class, 2021 & 2031F

10 Israel Orphan Drugs Market - Competitive Landscape

10.1 Israel Orphan Drugs Market Revenue Share, By Companies, 2024

10.2 Israel Orphan Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Orphan Drugs Market

Asia Orphan Drugs Market

Asia Pacific Orphan Drugs Market

Europe Orphan Drugs Market

Global Orphan Drugs Market

North America Orphan Drugs Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here